Boothbay Fund Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-27,400
Closed -$7.4M – 2023
2025
Q3
$7.4M Buy
27,400
+14,000
+104% +$3.81M 0.11% 220
2025
Q2
$3.69M Buy
+13,400
New +$3.64M 0.07% 361
2024
Q3
– Sell
-10,300
Closed -$2.02M – 1655
2024
Q2
$2.02M Sell
10,300
-7,300
-41% -$1.51M 0.05% 495
2024
Q1
$3.79M Buy
+17,600
New +$3.7M 0.07% 317
2022
Q2
– Sell
-1,100
Closed -$262K – 2305
2022
Q1
$262K Buy
+1,100
New +$258K 0.01% 1702

Other funds holding CME

Boothbay Fund Management's CME Position: Q2 2026 in Review

Boothbay Fund Management increased its CME Group (CME) stake by 89% in Q2 2026, buying an estimated $1.4M and bringing the position to 10,730 shares worth $2.37M. The position accounts for 0.03% of the portfolio, ranked #650.

Boothbay Fund Management first reported a position in CME in Q1 2017 and has held it in 12 quarters since. The position peaked at $7.89M in Q4 2025. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Boothbay Fund Management held 10,730 shares of CME Group worth $2.37M as of Q2 2026.
  • Boothbay Fund Management bought 5,058 CME Group shares in Q2 2026, an estimated $1.4M.
  • CME Group made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #650 holding.
  • Boothbay Fund Management first reported a position in CME Group in Q1 2017 and has held it in 12 quarters since.
  • Boothbay Fund Management's CME Group position peaked at $7.89M in Q4 2025.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.